Abilify and Gambling – Abilify Gambling Lawsuit Consolidated

Written By:
Jessie Paluch
Jessie Paluch

Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.

This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.

TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.

Abilify and Gambling – Abilify Gambling Lawsuit Consolidated

Abilify and gambling is a hot topic of recent TV commercials and lawyer advertisements, leading many to wonder whether abilify gambling lawsuit are in the future.

In fact, a number of Abilify gambling lawsuits filed against Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. alleging gambling side effects associated with the antipsychotic drug Abilify have been filed and were recently centralized in a Florida federal court.

Abilify use linked to compulsive gambling

The Judicial Panel on Multidistrict Litigation (JPML) said that centralizing the 22 lawsuits pending in 12 districts should eliminate duplicative discovery, conserve court resources, and prevent inconsistent pretrial rulings.

The cases were consolidated before Chief Judge M. Casey Rodgers, who is already presiding over two Abilify cases in Florida’s Northern District in Pensacola.

Table of Contents

What Drug Causes Compulsive Gambling?

Recent studies point to Abilify, a popular antipsychotic as a possible cause of compulsive gambling.

In 2014, a study published in the medical journal JAMA Internal Medicine reported evidence that dopamine receptor agonists (often used to treat Parkinson’s Disease) were linked to gambling and other impulse-control problems, the same behavioral problems associated with Abilify use.

Abilify (aripiprazole) is an antipsychotic drug that was approved by the FDA in 2002 to treat schizophrenia, bipolar disorder, depression, and autism spectrum disorders.

The medication has generated sales of more than $6 billion per year and was the top selling brand name drug on the market in 2013.

Although the European Medicines Agency has required Abilify warnings about the risk of compulsive gambling since 2012 and regulatory officials in Canada mandated similar warnings in late 2015, such warnings were not provided to consumers in the U.S. until May 3, 2016, when the U.S.

Food and Drug Administration (FDA) issued a warning that compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex have been reported with the use of Abilify.

Abilify Gambling Lawsuit

Product liability lawsuits against the Abilify makers allege that the companies withheld information from consumers as well as medical professionals regarding how Abilify use can lead to compulsive gambling and other behaviors.

The plaintiff in one case claims that after beginning Abilify in 2013, the side effects of the drug adversely impacted his brain and caused him to engage in pathological gambling behavior.

He claims substantial gambling losses, loss of employment, severe damage to his financial stability, and other mental and physical damages.

His gambling problems continued until soon after he stopped the medication in August 2015.

Written By:
Jessie Paluch
Jessie Paluch

Experienced Attorney & Legal SaaS CEO

With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three.  She spent the first decade of her career working as an international tax attorney at Deloitte.

In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.

In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!

Camp Lejeune Lawsuit

Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.

Tylenol Lawsuit

Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.

AFFF Lawsuit

Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.

Do You
Have A Case?

Here, at TruLaw, we’re committed to helping victims get the justice they deserve.

Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Helpful Sites & Resources